News News Select Year All Years 2026 (33) 2025 (34) 2024 (29) 2023 (30) 2022 (33) 2021 (27) 2020 (34) 2019 (32) 2018 (42) 2017 (35) 2016 (43) 2015 (53) 2014 (26) 2013 (21) 2012 (16) 2011 (6) 2010 (4) 2009 (5) 2007 (1) 2006 (1) Search News Found 505 Results Page 44 of 51« First«...102030...4243444546...50...»Last » September 22, 2014 DBV Technologies Announces Primary Endpoint Met in VIPES, Viaskin Peanut’s Phase IIb Clinical Trial in Peanut Allergy August 26, 2014 DBV Technologies to Attend the Goldman Sachs European Biotech Symposium July 28, 2014 DBV Technologies Reports Financial Results for the First Six Months of 2014 July 17, 2014 Consortium of Food Allergy Research Completes Recruitment of NIH-sponsored CoFar6 Phase II Trial with DBV’s Viaskin® Peanut in Treatment of Peanut Allergy July 17, 2014 DBV Technologies Completes last “food challenge” visit of last Peanut-Allergic patient in VIPES Phase IIb Clinical Study June 16, 2014 DBV Technologies to Present at Upcoming US Investors Conferences June 10, 2014 Five Scientific Communications at the European Academy of Allergy and Clinical Immunology Congress Further Support DBV’s EPITTM Disease Modifying Effect May 13, 2014 DBV Technologies Announces Clinical Trial Agreement to Develop a Treatment for Milk-Induced Eosinophilic Esophagitis in Children May 12, 2014 DBV Technologies to Host and Webcast Investor Day in New York City on May 21, 2014 April 17, 2014 DBV Technologies publishes its 2013 Registration Document and its 2013 Annual Financial Report Page 44 of 51« First«...102030...4243444546...50...»Last »
